SMi Group reports: 6th Annual Highly Potent API Conference will return in May 2022 SMi Group has been working the Highly Potent Active Pharmaceutical Ingredients industry for 6 years now which has enabled the perfect […]
SMi is delighted to announce the 6th annual Pre-Filled Syringes West Coast conference, to be held in San Diego. As part of SMi’s leading series of drug delivery device conferences, the 2022 event will provide […]
BioNTech and Regeneron have expanded their strategic partnership for advancing BNT116 plus Libtayo (cemiplimab) to treat advanced non-small cell lung cancer (NSCLC). Based on the FixVac platform of BioNTech, BNT116 is an investigational messenger ribonucleic […]
Nutcracker Therapeutics has secured $167m in a Series C funding round led by ARCH Venture Partners to develop messenger ribonucleic acid (mRNA) therapies to treat cancer. The RNA manufacturing platform of the company merges RNA […]
Eli Lilly and Company has suspended all investments and promotional works in Russia and will only deliver medicines for urgent medical ailments such as cancer and diabetes amid the Ukraine crisis. The company also halted […]